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SUMMARY
Vitamin B12 functions as a cofactor for methionine
synthase to produce the anabolic methyl donor
S-adenosylmethionine (SAM) and for methylma-
lonyl-CoA mutase to catabolize the short-chain fatty
acid propionate. In the nematode Caenorhabditis
elegans, maternally supplied vitamin B12 is required
for the development of offspring. However, the
mechanism for exporting vitamin B12 from the
mother to the offspring is not yet known. Here, we
use RNAi of more than 200 transporters with a
vitamin B12-sensor transgene to identify the ABC
transporter MRP-5 as a candidate vitamin B12
exporter. We show that the injection of vitamin B12
into the gonad of mrp-5 deficient mothers rescues
embryonic lethality in the offspring. Altogether, our
findings identify amaternal mechanism for the transit
of an essential vitamin to support the development of
the next generation.
INTRODUCTION
Maternal micronutrient status during pregnancy greatly affects
embryonic development and fetal health (Dror and Allen, 2008;
Fall et al., 2003; Owens and Fall, 2008; Skjærven et al., 2016).
For instance, the intake of folate supplements by pregnant
women reduces the occurrence of neural tube defects in
newborns (Czeizel and Duda´s, 1992; Viswanathan et al., 2017).
Folate functions together with vitamin B12, or cobalamin, in the
one carbon cycle to recycle methionine from homocysteine
(Moreno-Garcia et al., 2013) (Figure 1A). One of the main
functions of the one-carbon cycle is to produce S-adenosylme-
thionine (SAM), a major methyl donor required to synthesize
phosphatidylcholine, an important component of cellular mem-
branes, and to modify histones and DNA to ensure proper
genomic functions (Rosenblatt and Whitehead, 1999). The other
function of vitamin B12 is as a cofactor in the breakdown of the
short-chain fatty acid propionate (Shchelochkov et al., 2016)
(Figure 1A). Humans obtain vitamin B12 through the ingestion
of animal products in which this stable micronutrient is efficiently
stored (Martens et al., 2002). Deficiency of vitamin B12 in new-
borns is mostly caused either by maternal depletion or malab-
sorption, although rare recessive inborn errors of vitamin B12
processing or utilization have also been identified (Rosenblatt
and Cooper, 1990; Rosenblatt and Whitehead, 1999).
Recently, the nematode Caenorhabditis elegans has been
established as a powerful model for studying vitamin B12-
dependent processes (Yilmaz and Walhout, 2014). C. elegans
is a bacterivore that can be fed individual bacterial species
and strains that can elicit different effects on the animal’s
life history traits and gene expression. For instance, when fed
Comamonas aquatica DA1877 bacteria, the animals develop
faster, have reduced fecundity, and have a shorter lifespan rela-
tive to animals fed the standard laboratory diet of Escherichia
coli OP50 (MacNeil et al., 2013; Watson et al., 2013). These
dietary differences are due, at least in part, to the fact that
Comamonas synthesizes vitamin B12, whereas E. coli does
not (Watson et al., 2014). Dietary vitamin B12 is required to
support C. elegans development, as the animal itself cannot
synthesize this cofactor (Bito et al., 2013; Watson et al., 2014).
Vitamin B12 is ingested by the mother and needs to be exported
from the intestine into the gonad to support the development of
her offspring. However, the mechanism by which this occurs
is not yet known. Here, we report that the ABC transporter
mrp-5 controls vitamin B12 export from the intestine to support
C. elegans embryonic development.
RESULTS
An RNAi Screen Identifies the ABC Transporter MRP-5
as a Candidate to Export Vitamin B12 from the
C. elegans Intestine
We have previously established the Pacdh-1::GFP transgenic
C. elegans strain as a reporter of dietary vitamin B12 status: in
this strain, GFP is highly expressed when vitamin B12 is low
and repressed when levels of this micronutrient are high (Arda
et al., 2010; MacNeil et al., 2013; Watson et al., 2014; Watson
et al., 2016). GFP expression in this strain is under the control
of the promoter of the acyl-coenzyme A (CoA) dehydrogenase
acdh-1. This gene encodes the first enzyme of an alternate pro-
pionate breakdown pathway, or propionate shunt, which does
not require vitamin B12 and is transcriptionally activated when
this cofactor is in low supply (Watson et al., 2016)(Figure 1A).
We reasoned that a defect in vitamin B12 transport from the
mother to her offspring would result in parental generation
(P)0 animals with low levels of GFP in the presence of vitamin
3126 Cell Reports 22, 3126–3133, March 20, 2018 ª 2018 The Author(s).
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Figure 1. A C. elegans Transporter RNAi Screen Identifies mrp-5 as a Potential Vitamin B12 Exporter
(A) Cartoon of the two vitamin-B12-dependent metabolic pathways. Gene names are from C. elegans. 3HP, 3-hydroxypropionate; 5-meTHF, 5-methylte-
trahydrofolate; 5,10-meTHF, 5,10-methylenetetrahydrofolate; D-MM-CoA, D-methylmalonyl-CoA; Gly, glycine; HCy, homocysteine; L-MM-CoA, L-methyl-
malonyl-CoA; Met, methionine; MSA, malonic semialdehyde; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; THF, tetrahydrofolate. The acdh-1
branch in orange text indicates the vitamin-B12-independent propionate shunt.
(B) Diagram of C. elegans transporter RNAi library screen. RNAi-treated animals that displayed GFP fluorescence in the F1, but not the P0, generation in the
presence of 64 nM vitamin B12 were considered hits.
(C) Fluorescence and differential interference contrast (DIC) microscopy images of Pacdh-1::GFP animals subjected to RNAi ofmrp-5 in E. coliHT115 compared
to vector control at P0 and F1 generations in the presence or absence of 64 nM vitamin B12. Scale bars, 50 mm for embryos and 100 mm for adults.
(legend continued on next page)
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B12 and F1 embryos with high levels of GFP expression. Further,
these embryos would be expected to have developmental de-
fects, because vitamin B12 is required to produce SAM, which
is needed to generate biomass and, thus, support development
(Watson et al., 2014). We performed RNAi knockdown of 215
predictedC. elegans transporters of the ABC transporter and so-
lute carrier families by feeding animals E. coliHT115 bacteria ex-
pressing double-stranded RNA in the presence of 64 nM vitamin
B12 (Figure 1B). We identified a single gene, mrp-5, that, when
knocked down, resulted in mothers with low levels of GFP
expression and dead embryos with high GFP expression (Fig-
ure 1C). mrp-5 encodes an ABC transporter belonging to the
multi-drug resistance protein (MRP) family (Korolnek et al.,
2014). MRP proteins are highly similar, and the C. elegans
genome encodes nine family members (http://www.wormbase.
org). To test for specificity, we retested eight of the nine mem-
bers of this family for which RNAi clones were available and
found that onlymrp-5RNAi caused activation of GFP expression
in the F1 generation (Figure 1D). We then titrated vitamin B12
from 6.4 nM to 6.4 mM and found that GFP expression remains
activated in mrp-5 RNAi embryos even under very high vitamin
B12 conditions (Figure S1A).
MRP-5 is expressed in the intestine (Korolnek et al., 2014) (Fig-
ure S2). If mrp-5, indeed, encodes a transporter that exports
vitamin B12 from the C. elegans intestine to support embryonic
development, this would lead to the prediction that higher levels
of vitamin B12 should be retained in the intestine when the trans-
porter is perturbed. To test this prediction, we devised a highly
sensitive experimental setup by using (1) a single-copy Pacdh-
1::GFP::H2B strain that expresses GFP in the nucleus, enabling
easier monitoring of differences in GFP levels, and (2) an RNAi-
compatible strain of E. coli OP50 (Xiao et al., 2015), because an-
imals fed this diet express higher levels of GFP than those fed
E. coli HT115 (Figure S1B). Importantly, RNAi ofmrp-5 is equally
efficient in E. coli HT115 and E. coli OP50, as measured by qRT-
PCR (Figure S1C). We found that much lower concentrations of
vitamin B12 were sufficient to repress intestinal GFP in mrp-5
RNAi animals compared to vector control animals (Figures 1E
and 1F). This finding suggests that vitamin B12 is retained in
the intestine whenmrp-5 is knocked down. Together, these find-
ings indicate that mrp-5 encodes a transporter that exports
vitamin B12 from the intestine of the mother to support embry-
onic development of her offspring.
Injection of Vitamin B12 into the Gonad Rescues
Embryonic Lethality Caused by Loss ofmrp-5
We predicted that direct supplementation of vitamin B12 into
the gonad should bypass the requirement for vitamin B12
export from the intestine and rescue embryonic lethality caused
by perturbation of mrp-5. To test this prediction, we injected
either vitamin B12 or water (vehicle) as a control into the gonad
of Pacdh-1::GFP animals that were exposed to mrp-5 or vector
control RNAi. If the vitamin B12 injection into the gonad by-
passed MRP-5-dependent export, we expected to observe
live animals with low GFP expression, while injecting water
would lead to dead embryos with high GFP expression (Fig-
ure 2A). For this experiment, we used the E. coli OP50 RNAi
strains we generated (see also Figure 1E), because transgenic
Pacdh-1::GFP embryos express high levels of GFP, while they
express low GFP levels when fed E. coli HT115 bacteria (Fig-
ure S1). Using E. coli OP50 thus enabled us to observe a
decrease in GFP expression, while using E. coli HT115 would
not.
Injection of vitamin B12 into the gonad ofmrp-5 RNAi animals
fully and specifically rescued the embryonic viability of their
offspring (Figure 2B). In addition, inPacdh-1::GFP transgenic an-
imals exposed to mrp-5 RNAi, injecting vitamin B12 into the
gonad resulted in developed larvae with low levels of GFP, while
injection of water resulted in dead embryos with high GFP
expression (Figure 2B). We recapitulated these findings with
mrp-5(ok2067) deletion mutant animals. Since mrp-5 is an
essential gene, themrp-5 deletion allele ismaintained genetically
balanced with +/svT1[lon-2(e678)] (Figure 2C). Heterozygous
mrp-5 (+/) mothers injected with vitamin B12 into their gonad
producedmrp-5 (/) offspring that survived to the adult stage,
while animals injectedwith vehicle control producedmrp-5 (/)
animals that arrested at the L1–L2 stage (Figure 2D). Importantly,
the offspring of the rescued F1 mrp-5 (/) animals again ex-
hibited larval arrest, suggesting that, in the absence of mrp-5,
vitamin B12 cannot be passed on to the next (F2) generation.
Altogether, these findings show that vitamin B12 injected into
the gonad of a mrp-5 (+/) mother can rescue embryonic
lethality in her offspring.
Heme Rescues Embryonic Lethality inmrp-5 RNAi
Animals
A previous study proposed that mrp-5 encodes a heme trans-
porter (Korolnek et al., 2014). This finding was supported by
the observation that embryonic lethality in mrp-5 RNAi animals
could be rescued by feeding the animals high doses of heme
(Korolnek et al., 2014). How could either feeding of heme or injec-
tion of vitamin B12 rescue embryonic lethality of mrp-5 RNAi or
mutant animals? ABC transporters are known to be capable of
transporting numerous similar types of molecules (Lee and
Rosenbaum, 2017; Locher, 2016; Slot et al., 2011). Heme and
vitamin B12 share some structural similarities; heme is an iron-
containing porphyrin, while vitamin B12 is related to porphyrins
and contains cobalt as ametal ion (Figure 3A). Thus, it is possible
that MRP-5 transports both molecules. However, if lack of heme
and vitamin B12 explains the embryonic lethality of mrp-5 RNAi
(D) Fluorescence and DIC microscopy images of Pacdh-1::GFP animals subjected to RNAi ofmrp family members in E. coli HT115 compared to control RNAi in
the F1 generation. An RNAi clone for mrp-7 was not available. Scale bar, 50 mm.
(E) Fluorescence microscopy images of single-copy insertion Pacdh-1::GFP::H2B animals subjected to mrp-5 RNAi in E. coli OP50 compared to control RNAi
with low-dose titration of vitamin B12. Scale bar, 100 mm.
(F) Images from (E) were quantitated using ImageJ to determine the mean fluorescence intensity per animal. At least five animals were analyzed per condition.
Error bars represent SD. The p value was determined by unpaired multiple t tests, with a false discovery rate of 1% (*p < 0.0001).
See also Figures S1 and S2.
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animals, one would expect that neither cofactor alone would be
sufficient for rescue. Our observation that embryonic lethality
can be rescued by injection of vitamin B12 into the gonad indi-
cates that lack of vitamin B12 rather than hememay be the cause
of embryonic lethality when MRP-5 function is perturbed. To
further examine the effects of heme on animal development,
we repeated the experiment published in the previous study
(Korolnek et al., 2014) and confirmed that feeding 500 mM
heme can rescue embryonic lethality in the offspring of mrp-5
RNAi animals (Figure 3B). Interestingly, however, such a high
dose of heme was toxic to developing control animals, arresting
most animals at the L1–L2 stage, whereas high doses of vitamin
B12 were not toxic (Figure S3). Importantly, one can argue that
feeding heme does not actually test for transport, because the
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Figure 2. Injection of Vitamin B12 into the Gonad of mrp-5-Deficient Mothers Rescues Lethality in the Offspring
(A) Experimental design. Briefly, either 3.2mMvitamin B12 or water (vehicle) as a control was injected into the gonad ofPacdh-1::GFPmothers that were exposed
tomrp-5 or vector control RNAi. If the vitamin B12 injection rescues embryonic lethality, live offspring will show lowGFP expression, while water-injected animals
will show dead embryos with high GFP expression.
(B) Top: DIC and fluorescence microscopy images of embryos from Pacdh-1::GFPmothers subjected tomrp-5 RNAi in E. coli OP50 injected into the gonad with
water (left panel) or with 3.2 mM vitamin B12 (middle panel). Animals treated with vector control RNAi without injection are shown as a control (right panel). Scale
bars, 50 mm for embryos and 100 mm for adults. Bottom: quantification of lethality and GFP expression in embryos from Pacdh-1::GFP animals described above.
Error bars represent SD of the average of three independent experiments.
(C) Diagram of genotypes and phenotypes of the offspring of genetically balancedmrp-5 (+/) mutant animals. All P0 adult animals are heterozygous formrp-5.
F1 larval arrest or embryonic lethality occurs in mrp-5 (/) or szT1 aneuploid animals.
(D) Top: diagram of genotypes and phenotypes of viable offspring from genetically balancedmrp-5 (+/) mutant animals after vitamin B12 injection. All P0 adult
animals are heterozygous for mrp-5. Live F1 animals can be either heterozygous or homozygous for themrp-5(ok2067) deletion allele. The average percentage
and SD of the total number of L1-L2 animals is listed below the genotype. F2 larval arrest or embryonic lethality occurs in all offspring of the F2 generation of
mrp-5 (/) animals. Bottom left: DIC microscopy images of mrp-5 (+/) and mrp-5 (/) animals with or without vitamin B12 injection. Scale bar, 100 mm.
Bottom right: agarose gel image of the genotyping results of heterozygous and homozygous mrp-5 L1-L2 animals with and without injection of vitamin B12.
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cofactor would be stuck in the intestinewhenmrp-5 is perturbed,
which would, therefore, not result in the rescue of embryonic
development in the offspring.
One explanation for the rescue of embryonic development by
feeding heme is that this increases vitamin B12 passage through
intestinal membranes. Therefore, we next asked whether heme
affects the vitamin-B12-responsive Pacdh-1 reporter. We sup-
plemented increasing concentrations of heme and found that
the reporter was unaffected by heme in adult animals (Figure 3D).
As noted earlier, embryos from Pacdh-1::GFP mothers treated
with mrp-5 RNAi without supplemented heme expressed high
levels of GFP, suggesting that vitamin B12 cannot enter the em-
bryos and repress the reporter. Importantly, however, GFP levels
were greatly reduced in embryos from Pacdh-1::GFP/mrp-5
RNAi animals supplemented with 500 mM heme (Figure 3C).
These findings suggest that supplying a high dose of heme facil-
itates the export of vitamin B12 from the intestine and, therefore,
that the cause for embryonic lethality is lack of vitamin B12
and not heme. Indeed, we found that, while injection of vitamin
B12 into the gonad rescued embryonic development in Pacdh-
1::GFP/mrp-5 RNAi animals, direct injection of 200 mM heme
did not rescue. Further, the arrested L1 larvae from Pacdh-
1::GFP/mrp-5 RNAi animals injected with 200 mM heme
expressed high levels of GFP, indicating low vitamin B12 levels
(Figure 3E).
Methionine and SAM Content Is Reduced in Offspring
frommrp-5 RNAi Mothers
Although vitamin B12 is a cofactor for two different metabolic en-
zymes (Figure 1A), our previous studies demonstrated that the
developmental delay caused by vitamin B12 deficiency is mainly
due to its function as a cofactor for the methionine synthase
enzyme METR-1, which generates the methyl donor SAM from
methionine (Watson et al., 2014). To determine whether the
lack of vitamin B12 or the lack of heme in mrp-5-deficient ani-
mals results in defects in the SAM cycle, we measured the levels
of methionine and SAM in embryos from mothers treated with
mrp-5 or vector control RNAi. We reasoned that differences in
methionine and SAM content would be most clear in the pres-
ence of supplemented vitamin B12, because the E. coli diet is
naturally low in this cofactor. Indeed, we detected a reduced
methionine and SAM content in embryos from mothers treated
with mrp-5 RNAi relative to control animals in the presence of
vitamin B12 (Figures 4A and 4B). Further, SAM levels could be
restored to wild-type levels by feeding the animals with
500 mM heme. These results suggest that a defect in the SAM
A
B
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E
D Figure 3. High Concentrations of Heme
Rescue Embryonic Lethality in mrp-5 RNAi
Animals but Do Not Affect acdh-1 Promoter
Activity
(A) Heme and vitamin B12 are porphyrin or
porphyrin-likemoleculeswith structural similarities.
(B) Bright-field images of feeding 500 mM heme
to mrp-5 RNAi-treated mothers on E. coli HT115
rescues viability in her offspring and allows
them to develop to the L2 stage and later but
causes L1 larval arrest and toxicity in vector-
treated mothers. 24 singled mothers plus their
offspring were analyzed for each condition. Scale
bar, 500 mm.
(C) Fluorescence and DIC microscopy images
show that feeding 500 mM heme to mrp-5 RNAi-
treated mothers on E. coli HT115 reduces
Pacdh-1::GFP reporter activity in embryos but not
in the embryos of vector control mothers. 50 L1
mothers were seeded onto 6-cm plates, and F1
embryos were collected for imaging. Scale bar,
50 mm.
(D) Fluorescence and DIC microscopy images
demonstrate that feeding heme to P0 mothers
with E. coli OP50 does not affect Pacdh-1::GFP
reporter activity. Scale bar, 100 mm.
(E) Bright-field (top) and fluorescence and DIC
microscopy images (bottom) shows that injection
of 200 mM heme into mrp-5 RNAi-treated mothers
with E. coli HT115 does not rescue embryonic
lethality or larval arrest in the offspring, while in-
jection of vitamin B12 leads to viable offspring and
repression of the acdh-1 promoter. Scale bars,
500 mm for bright-field microscopy and 100 mm for
fluorescence microscopy.
See also Figure S3.
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cycle caused by the lack of vitamin B12 in mrp-5-deficient em-
bryos contributes to embryonic lethality.
DISCUSSION
We identified MRP-5 as a candidate transporter that exports
vitaminB12 from theC. elegans intestine of themother to support
the development of her offspring. MRP-5 is a member of the
C. elegans ABC transporter family, and these transporters are
known to function as exporters ofmetabolites and drugs (Locher,
2016; Sheps et al., 2004; Slot et al., 2011). MRP-5 has previously
been reported to export heme in C. elegans (Korolnek et al.,
2014). C. elegans can synthesize neither vitamin B12 nor heme
and depends on dietary supplementation of both cofactors.
Lossor reduction ofmrp-5byRNAi knockdownor bygeneticmu-
tation results in embryonic or larval lethality. As reported previ-
ously, we confirm that this lethality can be rescued by feeding
the mother high concentrations of heme. However, it can also
be rescued by injecting vitamin B12 directly into the gonad, by-
passing the need for import from the intestine and, perhaps, other
tissues. Wild-type C. elegans requires only low doses of heme
C
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Figure 4. Methionine and S-Adenosylmethio-
nine Content Is Reduced in Offspring from
Mothers Treated with mrp-5 RNAi
(A) SAM content was measured in the embryos of
vector or mrp-5 RNAi-treated mothers on E. coli
HT115. SAM content was greatly reduced inmrp-5-
deficient embryos compared to vector control. Error
bars represent SD of the average of three indepen-
dent experiments. The p value was determined
by Student’s t test relative to untreated embryos
(*p < 0.05; **p < 0.001; ***p < 0.0001).
(B) Methionine content was measured by GC-MS of
vector control or mrp-5 RNAi-treated mothers fed
E. coli HT115 with and without 64 nM vitamin B12
supplementation. Each dot represents a biological
replicate, and values are relative to vector RNAi
without vitamin B12 supplementation. The p value
was determined by Student’s t test (*p < 0.05).
(C) Model of MRP-5 function. In wild-type animals,
both vitamin B12 and heme are exported from the
intestine by MRP-5. Vitamin B12 can enter the em-
bryo and repress the acdh-1 reporter (top). In the
absence of MRP-5, neither vitamin B12 nor heme
can cross the intestinal membrane, the embryos
arrest, and the acdh-1 reporter remains active
(middle). The presence of 500 mM heme causes
membrane permeability inmrp-5-deficient mothers,
leading to vitamin B12 crossing the intestine mem-
brane, entering the embryo to rescue lethality, and
repressing the acdh-1 promoter (bottom).
(20 mM) (Rao et al., 2005), and high doses
of heme are toxic to many systems (Chiab-
rando et al., 2014). Indeed, supplementing
wild-type animals with a dose of 500 mM
heme was toxic to C. elegans as well,
whereas high doses of vitamin B12 were
not (Figures 3B and S3). One mechanism
of heme toxicity is by enhanced membrane
permeability (Chiabrando et al., 2014). Therefore, we propose
that supplementingmrp-5RNAi animalswith high concentrations
of heme leads to increased intestinal membrane permeability,
enabling both heme and vitamin B12 to pass through without
the need for a dedicated transporter (Figure 4C).
More than 15 human genes involved in vitamin B12 processing
have been identified (Nielsen et al., 2012), and four of these
encode transporters. One of these is the ABC transporter
MRP-1 (or ABCC1), which is localized to intestinal epithelial cells.
ABC transporters in human and C. elegans are highly similar in
sequence and structure. Therefore, we propose that C. elegans
MRP-5 may be a functional ortholog of human MRP1 to export
vitamin B12 from the intestine to surrounding tissues.
EXPERIMENTAL PROCEDURES
C. elegans Strains
All C. elegans strains were maintained at standard laboratory conditions as
described previously (Brenner, 1974), and strain N2 was used as wild-type.
Construction of VL749 (wwIs24 [Pacdh-1::GFP + unc-119(+)]) strain has been
previously described (Arda et al., 2010). Strain VL1168 (wwSi1[Pacdh-
1::GFP::H2B unc-119(+)] II;avr-14(ad1302) I; unc-119(ed3) III; avr-15(ad1051);
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glc-1(pk54) V) was generated by mos1-mediated single copy insertion (Frøk-
jaer-Jensen et al., 2008). Strain wwls47 [mrp5p::MRP-5::GFP + rol-6(+)] was
generatedby fusionPCR (http://www.wormbook.org). Themrp-5mutant strain
VC1599 (+/szT1 [lon-2(e678)] I;mrp-5(ok2067)/szT1 X) was obtained from the
C. elegans Genetics Center (CGC). Bacterial strains E. coli OP50, HT115, and
Comamonas aquatica DA1877 were obtained from CGC. The E. coli OP50
RNAi-compatible bacterial strain was generously provided by the Xu lab
(Xiao et al., 2015).
RNAi Screen
The Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used
to predict C. elegans ABC transporters and solute carrier transporters (Kane-
hisa et al., 2016). The transporter RNAi mini-library was generated by selecting
215 clones from both the ORFeome and Ahringer RNAi libraries (Kamath et al.,
2003; Rual et al., 2004). RNAi screening was carried out on 24-well nematode
growth medium (NGM) agar plates containing 2 mM isopropyl b-D-1-thioga-
lactopyranoside (IPTG), 50 mg/mL ampicillin with or without 64 nM Ado-Cbl
(vitamin B12). Pacdh-1::GFP animals were grown on regular NGM plates
with E. coli OP50 without Ado-Cbl supplementation for several generations
before harvesting embryos. Embryos were incubated in M9 buffer overnight
to obtain synchronized L1 animals. Approximately 15 L1 animals were added
to each well containing individual RNAi clones. Animal phenotypes were
observed after 80 hr of incubation, when the F1 generation was at the young
adult stage.
Quantitation of Fluorescence
The animal body was outlined, and fluorescence intensity of the animal was
determined using ImageJ (NIH). At least five animals per condition were
analyzed, and the mean fluorescence per animals was determined.
C. elegans qRT-PCR Experiments
Animals were synchronized by L1 arrest and grown on ampicillin and IPTG
plates seeded with either E. coli HT115 (vector RNAi and mrp-5 RNAi) or
E. coliOP50 (vector RNAi andmrp-5RNAi). Approximately 1,000 adult animals
were harvested for each condition, in biological duplicate. Animals were
washed in M9 buffer, and total RNA was isolated using TRIzol (Invitrogen) fol-
lowed by DNase I treatment and cleanup using QIAGEN RNeasy columns.
cDNAwasgenerated from1mgRNAusing randomprimer andM-MuLV reverse
transcriptase (New England Biolabs). qPCR was performed in technical dupli-
cates per gene per condition using the Applied Biosystems StepOnePlus
Real-Time PCR System and the Fast SYBR Green Master Mix (Thermo Fisher
Scientific). Relative transcript abundance was determined using the DDCt
method and normalized to averaged ama-1 mRNA expression levels.
Vitamin B12 Injections
Animals were treated with mrp-5 RNAi generated in an E. coli OP50 RNAi
compatible strain. Vitamin B12 (3.2 mM) was injected into the gonad of L4
animals using a Narishige microinjection arm attached to the body of a Nikon
Eclipse Ti inverted microscope. Sterile water was injected into the control
group. After injection, animals were singled and treated with the same RNAi
(mrp-5 or vector). Phenotypes were scored after 2 days. mrp-5(ok2067)
heterozygotes were singled at the L4 stage. Vitamin B12 was injected as
described earlier. After injection, animals were singled, and the phenotype
was scored after 5 days.
SAM Measurement
SAM was measured using the Bridge-It S-Adenosyl Methionine Fluores-
cence Assay Kit purchased from Mediomics following the manufacturer’s
recommendations.
Heme Solution Preparation
Hemin is the oxidized form of heme and must be dissolved in acid to make the
active form of heme. 10 mM hemin solution was prepared as described previ-
ously (Hickman and Winston, 2007). 6.5 mg/mL hemin (Sigma-Aldrich) was
dissolved in 0.1 M NaOH and incubated at 37C for 1 hr. 1 M Tris (pH 7.5)
was then added to a final concentration of 0.1 M. The pH was adjusted using
HCl, and the hemin solution was stored at 4C, protected from light, and used
within 2 days.
Relative Quantification of Methionine Using Gas
Chromatography-Mass Spectrometry
Approximately 150,000 embryos were homogenized with 0.5 mL 200- to
300-mm acid-washed glass beads (Sigma-Aldrich) in 1 mL 80% methanol us-
ing a FastPrep-24 bead beater (MP Biomedicals), with intermittent cooling in
dry ice/ethanol bath. Samples were then extracted on dry ice for 15 min and
centrifuged for 10 min at 20,0003 g, and 250 mL supernatant was dried under
vacuum using a SpeedVac concentrator SPD111V (Thermo Fisher Scientific).
Derivatization of dried samples was performed first with 20 mL 20 mg/mL
methoxyamine hydrochloride (Sigma-Aldrich) in pyridine at 37C for 90 min,
followed by the addition of 50 mL N-methyl-N-(trimethylsilyl)trifluoroacetamide
(Sigma-Aldrich) and incubation for 3 hr at 37C. The derivitazation reactionwas
completed by incubation for 5 hr at room temperature. Measurements were
performed on an Agilent 7890B/5977B single quadrupole GC-MS (gas chro-
matography-mass spectrometry) equipped with an HP-5ms Ultra Inert capil-
lary column (30 m 3 0.25 mm 3 0.25 mm). The inlet temperature was set to
230C, the transfer line was at 280C, and the MS source and quadrupole
were at 230C and 150C, respectively. The trimethylsilyl derivative of methi-
onine was quantified as a 176-m/z ion with two qualifier ions of 128 and 293
m/z. Relative quantification of peak areas was done using samples within a
linear response range, after mean normalization to total metabolites and blank
subtraction.
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